170 related articles for article (PubMed ID: 21897388)
21. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
22. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
[TBL] [Abstract][Full Text] [Related]
23. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.
Su F; Hu X; Jia W; Gong C; Song E; Hamar P
J Surg Res; 2003 Jul; 113(1):102-8. PubMed ID: 12943817
[TBL] [Abstract][Full Text] [Related]
24. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
[TBL] [Abstract][Full Text] [Related]
26. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate.
Moskaluk CA; Duray PH; Cowan KH; Linehan M; Merino MJ
Cancer; 1997 Apr; 79(8):1595-9. PubMed ID: 9118044
[TBL] [Abstract][Full Text] [Related]
28. Axillary nodal metastatic burden in patients with breast cancer with clinically positive axillary nodes.
Niinikoski L; Hukkinen K; Leidenius MHK; Heikkilä P; Mattson J; Meretoja TJ
Br J Surg; 2020 Nov; 107(12):1615-1624. PubMed ID: 32492194
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.
Zhao J; Hu C; Wang C; Yu W; Guo Y; Shi M; Shui Y; Wei Q
BMC Cancer; 2018 Dec; 18(1):1290. PubMed ID: 30587150
[TBL] [Abstract][Full Text] [Related]
30. False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients.
Loh ZJ; Lee KT; Chen YP; Kuo YL; Chung WP; Hsu YT; Huang CC; Hsu HP
World J Surg Oncol; 2021 Jun; 19(1):183. PubMed ID: 34158071
[TBL] [Abstract][Full Text] [Related]
31. Value of glutathion-S transferase pi as a prognostic factor in epithelial ovarian carcinoma.
Saip P; Tuzlali S; Demir K; Sakar B; Yavuz E; Berkman S; Bengisu E; Topuz E
Eur J Gynaecol Oncol; 2005; 26(1):90-4. PubMed ID: 15755010
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of fine needle aspirates processed by ThinPrep® for the assessment of axillary lymph node status in patients with invasive carcinoma of the breast.
Jing X; Wey E; Michael CW
Cytopathology; 2013 Dec; 24(6):372-6. PubMed ID: 23020285
[TBL] [Abstract][Full Text] [Related]
35. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.
Chauhan H; Abraham A; Phillips JR; Pringle JH; Walker RA; Jones JL
J Clin Pathol; 2003 Apr; 56(4):271-6. PubMed ID: 12663638
[TBL] [Abstract][Full Text] [Related]
36. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
37. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of ultrasound-guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer.
van Wely BJ; de Wilt JH; Francissen C; Teerenstra S; Strobbe LJ
Br J Surg; 2015 Feb; 102(3):159-68. PubMed ID: 25354962
[TBL] [Abstract][Full Text] [Related]
39. Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases.
Verheuvel NC; Ooms HW; Tjan-Heijnen VC; Roumen RM; Voogd AC
Breast; 2016 Jun; 27():175-81. PubMed ID: 27123958
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]